IN2014DE00193A - - Google Patents

Info

Publication number
IN2014DE00193A
IN2014DE00193A IN193DE2014A IN2014DE00193A IN 2014DE00193 A IN2014DE00193 A IN 2014DE00193A IN 193DE2014 A IN193DE2014 A IN 193DE2014A IN 2014DE00193 A IN2014DE00193 A IN 2014DE00193A
Authority
IN
India
Prior art keywords
arthritis
collagen
administration
relates
present
Prior art date
Application number
Other languages
English (en)
Inventor
Paul Dijkstra
Francis Chun LAU
James Lugo
Original Assignee
Interhealth Nutraceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interhealth Nutraceuticals Inc filed Critical Interhealth Nutraceuticals Inc
Publication of IN2014DE00193A publication Critical patent/IN2014DE00193A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN193DE2014 2013-10-24 2014-01-21 IN2014DE00193A (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361895332P 2013-10-24 2013-10-24

Publications (1)

Publication Number Publication Date
IN2014DE00193A true IN2014DE00193A (cg-RX-API-DMAC7.html) 2015-05-01

Family

ID=51610711

Family Applications (1)

Application Number Title Priority Date Filing Date
IN193DE2014 IN2014DE00193A (cg-RX-API-DMAC7.html) 2013-10-24 2014-01-21

Country Status (14)

Country Link
US (1) US9066926B2 (cg-RX-API-DMAC7.html)
KR (1) KR101664290B1 (cg-RX-API-DMAC7.html)
AR (1) AR095104A1 (cg-RX-API-DMAC7.html)
AU (1) AU2014202041B8 (cg-RX-API-DMAC7.html)
BR (1) BR112014011741A2 (cg-RX-API-DMAC7.html)
CA (1) CA2846644C (cg-RX-API-DMAC7.html)
CL (1) CL2014001281A1 (cg-RX-API-DMAC7.html)
CO (1) CO7020846A2 (cg-RX-API-DMAC7.html)
IN (1) IN2014DE00193A (cg-RX-API-DMAC7.html)
MX (1) MX347669B (cg-RX-API-DMAC7.html)
MY (1) MY180106A (cg-RX-API-DMAC7.html)
PH (1) PH12014501453A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201403524RA (cg-RX-API-DMAC7.html)
WO (1) WO2015060888A1 (cg-RX-API-DMAC7.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10226513B2 (en) 2015-01-09 2019-03-12 Mark Terrell Smith Method and composition to prevent or improve symptoms of musculoskeletal distress degeneration
WO2018052695A1 (en) * 2016-09-16 2018-03-22 Boston Scientific Neuromodulation Corporation System for pain management using heart sounds
EP3932298A1 (en) 2016-09-27 2022-01-05 Boston Scientific Neuromodulation Corporation System for pain management using objective pain measure
US10610688B2 (en) 2016-09-27 2020-04-07 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop pain management
US11793217B1 (en) 2016-10-04 2023-10-24 Lonza Greenwood Llc Method of manufacture and pasteurization of products containing undenatured collagen
KR102556540B1 (ko) * 2016-10-12 2023-07-18 어드밴스드 바이오매트릭스, 인코포레이티드 천연 세포외기질 분자로 제조된 3차원(3-d) 프린팅 잉크
EP4643934A3 (en) 2016-10-25 2025-11-26 Boston Scientific Neuromodulation Corporation System for pain management using baroreflex sensitivity
EP3568861B1 (en) 2017-01-11 2024-12-11 Boston Scientific Neuromodulation Corporation Pain management based on emotional expression measurements
US10631777B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on functional measurements
US10631776B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on respiration-mediated heart rates
US10729905B2 (en) 2017-01-11 2020-08-04 Boston Scientific Neuromodulation Corporation Pain management based on muscle tension measurements
EP3568069B1 (en) 2017-01-11 2021-04-28 Boston Scientific Neuromodulation Corporation Pain management based on brain activity monitoring
US11089997B2 (en) 2017-01-11 2021-08-17 Boston Scientific Neuromodulation Corporation Patient-specific calibration of pain quantification
US10960210B2 (en) 2017-02-10 2021-03-30 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management with sleep detection
CN106713191B (zh) * 2017-02-28 2020-09-08 西安电子科技大学 一种多级搜索sage方法
CN107048412A (zh) * 2017-04-26 2017-08-18 北京盛美诺生物技术有限公司 一种含有ⅱ型胶原蛋白的咀嚼型产品
US10898718B2 (en) 2017-07-18 2021-01-26 Boston Scientific Neuromoduiation Corporation Sensor-based pain management systems and methods
EP3655018B1 (en) * 2017-08-21 2025-02-26 Lonza Greenwood LLC Composition and nutritional supplement made therefrom
EP3658234A1 (en) * 2017-08-31 2020-06-03 Lonza LLC Health promoting composition and methods of use supplement related applications
IT201700111939A1 (it) * 2017-10-05 2019-04-05 Jointherapeutics S R L Composizione farmaceutica per l’uso nel trattamento di stati infiammatori
BR112021000860A2 (pt) * 2018-07-16 2021-04-13 Lonza Consumer Health Inc. Suplemento de colágeno e matéria celular e método para administrar o mesmo
WO2021016665A1 (en) * 2019-07-30 2021-02-04 Atp Institute Pty Ltd A gummy composition
CA3152428A1 (en) 2019-09-30 2021-04-08 Kevin Owen Cannabinoid product for improving musculoskeletal health
US20230248808A1 (en) 2020-01-29 2023-08-10 Lonza Greenwood Llc Joint Health Composition and Use Thereof in Healthy Mammals
EP4096414A1 (en) 2020-03-03 2022-12-07 Lonza Greenwood LLC Undenatured type ii collagen in food and beverage applications and uses thereof
MX2022010859A (es) 2020-03-24 2022-11-08 Lonza Greenwood Llc Colageno tipo ii sin desnaturalizar en alimentos y golosinas para animales.
US20230256060A1 (en) * 2020-06-12 2023-08-17 Lonza Greenwood Llc Undenatured Type II Collagen as a Supplement for Improved Endurance, Lipid Metabolism, and Oxidative Stress
US20230284668A1 (en) * 2020-08-19 2023-09-14 Lonza Consumer Health Inc. Method for Improving Inflammation, Joint Health, Joint Mobility, and Joint Comfort in Healthy Mammals
CN115120618B (zh) * 2021-03-23 2024-01-26 安徽盛美诺生物技术有限公司 具有改善免疫应答作用的软骨提取物、其制备方法及其用途
EP4412637A4 (en) * 2021-11-12 2025-08-27 Lonza Greenwood Llc METHOD OF TREATING SKELETAL JOINTS, COMPOSITION AND ASSOCIATED USES
KR102771944B1 (ko) * 2023-09-25 2025-02-26 (주)온오퍼 고함량 액티브 성분을 갖는 반려동물용 츄 형태 영양제

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
EP0565678A1 (en) 1991-11-08 1993-10-20 LOFGREN NISSER, Gunilla Partially occluded contact lens for treating visual and/or brain disorder
US5637321A (en) 1994-02-28 1997-06-10 Moore; Eugene R. Method for preparing animal tissue for use in alleviating the symptoms of arthritis in mammals
US5529786A (en) 1994-02-28 1996-06-25 Moore; Eugene R. Process and product for treatment of rheumatoid arthritis
US5645851A (en) 1994-02-28 1997-07-08 Moore; Eugene R. Product for alleviating the symptons of arthritis in mammals
US6162787A (en) 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
US6372794B1 (en) * 1999-08-26 2002-04-16 Marcel E. Nimni Method for alleviating arthritis in mammals
US20020086070A1 (en) 2000-03-11 2002-07-04 Kuhrts Eric Hauser Anti-inflammatory and connective tissue repair formulations
US7083820B2 (en) 2000-09-29 2006-08-01 Schilling Marvin L Method for producing biologically active products
JP2003048850A (ja) 2001-06-01 2003-02-21 Nippon Meat Packers Inc 関節傷害治療剤及び機能性食品
US20060062859A1 (en) 2004-08-05 2006-03-23 Kenneth Blum Composition and method to optimize and customize nutritional supplement formulations by measuring genetic and metabolomic contributing factors to disease diagnosis, stratification, prognosis, metabolism, and therapeutic outcomes
FR2900155B1 (fr) * 2006-04-21 2008-06-27 Diana Naturals Sa Hydrolisat de cartilage aviaire, procede d'obtention et utilisations
US20100215731A1 (en) 2009-02-20 2010-08-26 Maastricht University Method for improving cartilage repair and/or preventing cartilage degeneration in a joint
US20110218151A1 (en) * 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate
CN101822684B (zh) 2010-05-27 2012-08-15 江苏江山制药有限公司 用于防治骨关节痛的复方组合制剂及其制备方法
US20120294898A1 (en) 2011-05-19 2012-11-22 Warsaw Orthopedic, Inc. Injectable dbm for soft tissue repair
CN102423487B (zh) 2011-12-23 2014-04-16 内蒙古伊利实业集团股份有限公司 一种骨关节保健组合物及其应用
CN103203012A (zh) 2012-01-12 2013-07-17 深圳市麦金利实业有限公司 关节保健品

Also Published As

Publication number Publication date
BR112014011741A2 (pt) 2017-05-30
CA2846644A1 (en) 2015-07-13
AU2014202041B8 (en) 2020-04-02
MX347669B (es) 2017-05-08
KR20150059132A (ko) 2015-05-29
SG11201403524RA (en) 2015-05-28
PH12014501453B1 (en) 2015-01-21
CL2014001281A1 (es) 2015-10-30
PH12014501453A1 (en) 2015-01-21
MY180106A (en) 2020-11-23
AU2014202041A1 (en) 2015-05-14
US20150119335A1 (en) 2015-04-30
AU2014202041B2 (en) 2019-11-28
AR095104A1 (es) 2015-09-30
CA2846644C (en) 2018-05-01
CO7020846A2 (es) 2014-08-11
US9066926B2 (en) 2015-06-30
KR101664290B1 (ko) 2016-10-11
MX2014002934A (es) 2015-09-21
WO2015060888A1 (en) 2015-04-30

Similar Documents

Publication Publication Date Title
IN2014DE00193A (cg-RX-API-DMAC7.html)
CY1123065T1 (el) Ανασυνδυασμενα προβιοτικα βακτηριδια
UA110813C2 (uk) Лікування ліподистрофії
MY172578A (en) Oral dosing of glp-1 compounds
GB201711353D0 (en) Improvements relating to face recognition
MX2015014500A (es) Terapia de combinacion de anticuerpos contra csf-1r y agonista de tlr9.
MX369067B (es) Método para reducir la producción de gas total y/o la producción de metano en un animal rumiante.
ECSP15043422A (es) Un procedimiento para aumentar la formacion de acido piroglutamico de una proteina
EA201591661A1 (ru) Пептиды и композиции для лечения повреждений суставов
EA201791110A1 (ru) Сублингвальное введение рилузола
EA201600026A1 (ru) Бактериальная гиалуронидаза и способ ее производства
PH12016500598A1 (en) Protoxin-ii variants and methods of use
EA201690855A1 (ru) Эндоглиновые пептиды для лечения фиброзных заболеваний
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
MY190747A (en) Method for producing silazane-siloxane copolymers and the use of such copolymers
SG10201804034QA (en) Methods for treating hypotension
DK201300055U4 (da) Tæppe med kanaler fyldt med i det væsentlige sfæriske objekter til terapeutisk behandling
EA201690075A1 (ru) Способ лечения внутриклеточной инфекции
MX2016005545A (es) Analogo de la relaxina humana, composicion farmaceutica del mismo y aplicacion farmaceutica del mismo.
MX2016012758A (es) Composicion hiperosmolar de acido hialuronico.
IN2013MU01113A (cg-RX-API-DMAC7.html)
IL242911B (en) Tin-117m for treatment of immune, inflammatory and degenerative arthritides
EA201690445A1 (ru) Лечение рака
EA201690446A1 (ru) Лечение множественной миеломы
MX2016005645A (es) Composicion farmaceutica topica de acitretina.